These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 17605948)

  • 21. Management of Gonorrhea in Adolescents and Adults in the United States.
    Kidd S; Workowski KA
    Clin Infect Dis; 2015 Dec; 61 Suppl 8(Suppl 8):S785-801. PubMed ID: 26602618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decrease in the incidence of tetracycline resistance in strains of Neisseria gonorrhoeae in the nineties.
    Bodonaik NC
    West Indian Med J; 2003 Sep; 52(3):228-30. PubMed ID: 14649105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An audit of pharyngeal gonorrhoea treatment in a public sexual health clinic in Adelaide, South Australia.
    Hustig A; Bell C; Waddell R
    Int J STD AIDS; 2013 May; 24(5):399-400. PubMed ID: 23970709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gonococcal resistance: evolving from penicillin, tetracycline to the quinolones in South Africa -- implications for treatment guidelines.
    De Jongh M; Dangor Y; Adam A; Hoosen AA
    Int J STD AIDS; 2007 Oct; 18(10):697-9. PubMed ID: 17945048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variation in adherence to the treatment guidelines for Neisseria gonorrhoeae by clinical practice setting, California, 2009 to 2011.
    Lechtenberg RJ; Samuel MC; Bernstein KT; Lahiff M; Olson N; Bauer HM
    Sex Transm Dis; 2014 May; 41(5):338-44. PubMed ID: 24722391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential deleterious effects of promoting the use of ceftriaxone in the treatment of Neisseria gonorrhoeae.
    Golden MR; Barbee LA; Kerani R; Dombrowski JC
    Sex Transm Dis; 2014 Oct; 41(10):619-25. PubMed ID: 25211259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. "Ophthalmia Venerea": A dreadful complication of fluoroquinolone-resistant Neisseria gonorrhoeae.
    Guerrero ML; Alfaro IJ; Sandoval BG; Górgolas M
    Sex Transm Dis; 2010 May; 37(5):340-1. PubMed ID: 20429088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of antimicrobial resistance in Neisseria gonorrhoeae in an HIV/AIDS clinic.
    Chan DJ; Tapsall J
    Int J STD AIDS; 2006 Jun; 17(6):410-2. PubMed ID: 16734965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zabofloxacin (DW-224a) activity against Neisseria gonorrhoeae including quinolone-resistant strains.
    Jones RN; Biedenbach DJ; Ambrose PG; Wikler MA
    Diagn Microbiol Infect Dis; 2008 Sep; 62(1):110-2. PubMed ID: 18620833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gonorrhea. CDC recommended treatment schedules, 1978.
    J Med Assoc State Ala; 1979 Aug; 49(2):32-3, 48, 51. PubMed ID: 227978
    [No Abstract]   [Full Text] [Related]  

  • 31. First case of spectinomycin resistant Neisseria gonorrhoeae isolate in New Delhi, India.
    Bala M; Ray K; Salhan S
    Sex Transm Infect; 2005 Apr; 81(2):186-7. PubMed ID: 15800110
    [No Abstract]   [Full Text] [Related]  

  • 32. Outpatient management of severe gonococcal ophthalmia without genital infection.
    Annan NT; Boag FC
    Int J STD AIDS; 2008 Aug; 19(8):573-4. PubMed ID: 18663052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends of sexually transmitted diseases and antimicrobial resistance in Neisseria gonorrhoeae.
    Matsumoto T
    Int J Antimicrob Agents; 2008 Feb; 31 Suppl 1():S35-9. PubMed ID: 18164598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gonorrhea. CDC recommended treatment schedules, 1978.
    J Okla State Med Assoc; 1979 Jun; 72(6):183-7. PubMed ID: 224158
    [No Abstract]   [Full Text] [Related]  

  • 35. Adherence to Centers for Disease Control and Prevention Gonococcal Treatment Guidelines Among Chicago Health Care Providers, 2011-2012.
    Tabidze IL; Nicholson TF; Mikati T; Benbow N; Mehta SD
    Sex Transm Dis; 2015 Aug; 42(8):422-8. PubMed ID: 26165433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial susceptibility profile of Neisseria gonorrhoeae isolated from patients attending a STD facility in Maputo, Mozambique.
    Apalata T; Zimba TF; Sturm WA; Moodley P
    Sex Transm Dis; 2009 Jun; 36(6):341-3. PubMed ID: 19556927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The outcome of oropharyngeal gonorrhoea treatment with different regimens.
    Harry TC
    Int J STD AIDS; 2005 Jul; 16(7):520. PubMed ID: 16004640
    [No Abstract]   [Full Text] [Related]  

  • 38. Gonorrhea treatment practices in the STD Surveillance Network, 2010-2012.
    Kerani RP; Stenger MR; Weinstock H; Bernstein KT; Reed M; Schumacher C; Samuel MC; Eaglin M; Golden M
    Sex Transm Dis; 2015 Jan; 42(1):6-12. PubMed ID: 25504294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibiotic resistance in Neisseria gonorrhoeae is diminishing available treatment options for gonorrhea: some possible remedies.
    Tapsall J
    Expert Rev Anti Infect Ther; 2006 Aug; 4(4):619-28. PubMed ID: 17009941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Further increase of quinolone resistance of gonococci in the Netherlands and proposal for a new surveillance].
    Koedijk FD; Borgen K; van Loo IH; van de Laar MJ
    Ned Tijdschr Geneeskd; 2007 Jan; 151(2):142-3. PubMed ID: 17315494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.